Completed NA INTERVENTIONAL 1-arm NCT00210106

Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. (ARF2003)

Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.

Sponsor: Institut Bergonié

Conditions Colorectal Cancer

Interventions Ablathermy

Updated 6 times since 2017 Last updated: Apr 27, 2021 Started: Jun 30, 2003 Primary completion: Dec 31, 2008 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Colorectal Cancer, this trial is completed. The trial is conducted by Institut Bergonié and has accumulated 6 data snapshots since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2021 — Jul 2024 [monthly]

Completed NA

Phase: PHASE2 → NA
Jan 2021 — Jun 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Bergonié

Data source: Institut Bergonié

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Angoulême, France , Bordeaux, France , Clamart, France , Le Bouscat, France , Lyon, France , Montpellier, France , Niort, France , Pau, France , Pessac, France and 1 more location